SavedAdd your journal

Journals / Acta Orthopaedica et Traumatologica Turcica / 2000 / Cilt: 34 - Sayı: 3

Percutaneous autogenous bone-marrow injection in delayed union and nonunion of long bone fractures: A preliminary report

Uzun kemiklerde kaynama gecikmesi ve yokluğunun perkütanöz kemik iliği enjeksiyonu ile tedavisi: Erken sonuçların bildirimi

Mehmet ARAZİ
Tunç C. ÖĞÜN
Mahmut MUTLU
Erol ERTÜRK
Abdurrahman KUTLU
Pages
267–272
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results suggest that percutaneous autogenous bone-marrow injection is a safe, simple, and effective alternative in the treatment of union problems of long bone fractures in selected patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To evaluate the clinical effectiveness of percutaneous autogenous bone-marrow injection in delayed union and nonunion of long bone fractures.
📊
Key Findings & Data:Methods: In this prospective study, eight patients (2 women, 6 men; mean age 34.3 years; range 20-47 years) who developed delayed union or nonunion of long bone fractures were treated with percutaneous autogenous bone-marrow grafting.
💡
Conclusion & Impact:Conclusion: The results suggest that percutaneous autogenous bone-marrow injection is a safe, simple, and effective alternative in the treatment of union problems of long bone fractures in selected patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Humerus kırıkları · Nakil · otolog

Abstract

Objectives: To evaluate the clinical effectiveness of percutaneous autogenous bone-marrow injection in delayed union and nonunion of long bone fractures. Methods: In this prospective study, eight patients (2 women, 6 men; mean age 34.3 years; range 20-47 years) who developed delayed union or nonunion of long bone fractures were treated with percutaneous autogenous bone-marrow grafting. The fractures were localized in the tibia (n=3), humerus (n=2), ulna (n=2) and, radius (n=1). Results: One patient dropped out of follow-up. Five of the remaining patients achieved sufficient union and healing in a mean duration of 4.2 months (range 3-6 months). Conclusion: The results suggest that percutaneous autogenous bone-marrow injection is a safe, simple, and effective alternative in the treatment of union problems of long bone fractures in selected patients.

Özet

Amaç: Perkütan kemik iliği enjeksiyonunun uzun kemik kaynama problemlerinin tedavisinde klinik etkinliğini değerlendirmek. Çalışma planı: Uzun kemik kırığı bulunan ve kaynama problemi olan sekiz hasta (2 kadın, 6 erkek; ortalama yaş 34.3; yaş dağılımı 20-47) perkütan kemik iliği enjeksiyonu ile tedavi edildi ve prospektif olarak değerlendirildi. Kırıkların lokalizasyonları tibia (n=3), humerus (n=2), ulna (n=2) ve radius (n=1) şeklindeydi. Sonuçlar: Bir hasta takipten ayrıldı, kalan yedi hastanın beşinde, ortalama 4.2 ayda (3-6 ay) yeterli kaynama elde edildi. Çıkarımlar: Seçilmiş hastalarda, kaynama problemlerinin tedavisinde, perkütanöz kemik iliği enjeksiyonunun, emniyetli, basit ve alternatif bir tedavi yaklaşımı olduğu sonucuna varıldı.

🔖

Cite This Article

ARAZİ, M., ÖĞÜN, T. C., MUTLU, M., ERTÜRK, E., KUTLU, A. (2000). Percutaneous autogenous bone-marrow injection in delayed union and nonunion of long bone fractures: A preliminary report. Acta Orthopaedica et Traumatologica Turcica, Cilt: 34 - Sayı: 3, 267–272. https://ajindex.com/articles/354552

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Connolly JF, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg [Am] 1989;71:684-91
  2. Connolly JF. Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis. Clin Orthop 1998;(355 Suppl):S257-66
  3. McKibbin B. The biology of fracture healing in long bones. J Bone Joint Surg [Br] 1978;60:150-62
  4. Schenk RK. Histophysiology of bone remodelling and bone repair. In: Lin OC, Chao EY, editors. Perspectives on biomaterials. 1st ed. Amsterdam: Elsevier Science Publishers; 1986.p. 75-94
  5. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop 1991;(266):259-70
  6. Connolly JF. Injectable bone marrow preparations to stimulate osteogenic repair. Clin Orthop 1995;(313):8-18
  7. Einhorn TA. Enhancement of fracture-healing. J Bone Joint Surg [Am] 1995;77:940-56
  8. Erler K, Baydar ML, Aydoğan N, Kırdemir V, Gür E. Nonunionların demineralize kemik matriksi ve kemik iliğinin kombine enjeksiyonu ile tedavisi. Hacettepe Ortop Derg 1994;4:209-14
  9. Garg NK, Gaur S, Sharma S. Percutaneous autogenous bone marrow grafting in 20 cases of ununited fracture. Acta Orthop Scand 1993;64:671-2
  10. Garg NK, Gaur S. Percutaneous autogenous bone-marrow grafting in congenital tibial pseudarthrosis. J Bone Joint Surg [Br] 1995;77:830-1
  11. Healey JH, Zimmerman PA, McDonnell JM, Lane JM. Percutaneous bone marrow grafting of delayed union and nonunion in cancer patients. Clin Orthop 1990;(256):280-5
  12. Sharma S, Garg NK, Veliath AJ, Subramanian S, Srivastava KK. Percutaneous bone-marrow grafting of osteotomies and bony defects in rabbits. Acta Orthop Scand 1992;63:166-9
  13. O’Sullivan ME, Chao EY, Kelly PJ. The effects of fixation on fracture-healing. J Bone Joint Surg [Am] 1989;71:306-10
  14. Lokiec F, Ezra E, Khermosh O, Wientroub S. Simple bone cysts treated by percutaneous autologous marrow grafting. A preliminary report. J Bone Joint Surg [Br] 1996;78:934-7. 15.Wientroub S, Goodwin D, Khermosh O, Salama R. The clinical use of autologous marrow to improve osteogenic potential of bone grafts in pediatric orthopedics. J Pediatr Orthop 1989;9:186-90
  15. Köse N, Göktürk E, Turgut A, Günal I, Seber S. Percutaneous autologous bone marrow grafting for simple bone cysts. Bull Hosp Joint Dis 1999;58:105-10.